[Stereotactic radiotherapy following chemo-radiotherapy for lymph node metastasis of stage III non-small-cell lung cancer].
It has been expected that stereotactic radiotherapy (SRT) is one of the useful treatments for non-resectable early lung cancer. In the case radiotherapy was thought to be difficult due to the wideness of irradiation area, it is probable to undergo chemo-radiotherapy safely using SRT for a primary lesion. We report two cases of Stage III non-small-cell lung cancer, which underwent SRT for primary tumors following chemo-radiotherapy for the lymph node metastasis. In both two cases, a reduction of V₂₀ (the normal pulmonary volume to receive radiation exposure: more than 20 Gy) was a possibility, and symptomatic radiation pneumonitis was not observed.
Division of Respiratory, Medicine and Medical Oncology, Gifu Municipal Hospital.
Yohei
Y
Futamura
Toshiyuki
T
Sawa
Takaaki
T
Hasegawa
Akane
A
Horiba
Takashi
T
Ishiguro
Tsutomu
T
Yoshida
Takayoshi
T
Iida
Tsutomu
T
Marui
Eiji
E
Murakami
Ken-Ichiro
K
Azuma
Shinji
S
Murakawa
D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy; D059248:Chemoradiotherapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009367:Neoplasm Staging; D011829:Radiation Dosage; D013238:Stereotaxic Techniques; D014057:Tomography, X-Ray Computed